Grecia, Costa Rica – April 22, 2025 – AVNA INC., a leader in advanced manufacturing of medical device components and subassemblies, has officially relocated and expanded its Costa Rica operations to the new
Evolution Free Zone, in
Grecia Costa Rica.
With an investment of USD 5.5 million and a 116% increase in production capacity, these opening positions the company as the anchor tenant of the business park and reinforces its commitment to innovation and growth in Costa Rica.
The new AVNA facility spans 5,900 m², of which 5,200 m² is dedicated to production and 700 m² to administrative operations. This expansion will allow the company to incorporate advanced technologies such as laser processing, plastic injection molding and overmolding, precision grinding technology for blades/sharps, CNC machining, and advanced automation and assembly.
“
Choosing Costa Rica as a key location for AVNA’s growth was a strategic decision driven by our customers’ needs and the country’s ability to foster mutually beneficial business partnerships that optimize supply chain, quality, and advancement of life-improving technology,” said Jason Howey, CEO of AVNA. “
The country is home to a large talented pool of professionals with an innovative mindset, which perfectly aligns with our commitment to excellence and technological advancement. Furthermore, Costa Rica’s strong sense of community and its ability to provide a high quality of life for our employees reinforces our belief that this is the ideal place to expand and deliver value to our customers and the local community”.
Additionally, Vice President – Costa Rica Operations Mario Chaves, added: “
We have been present in Costa Rica for over 13 years, and I can attest to our evolution into a more complex operation, integrating advanced automation, data-driven decision-making, and collaboration with global teams. This organizational growth aligns perfectly with our adoption of the name AVNA – 'Advanced Innovation' – which we implemented in 2024.”
Costa Rica: A Strategic DestinationCosta Rica continues to strengthen its position as a key destination for foreign investment in
advanced manufacturing and
medical devices. AVNA’s expansion in Evolution Free Zone is a testament to the trust that companies place in Costa Rican talent and the country’s favorable business environment, where 14 of the top 30 multinational companies in the life sciences sector operate.
“
We have been with AVNA from the very beginning in Costa Rica, over 13 years ago, so we clearly understand its evolutionary process in the country. Today, we celebrate this significant growth, which will strengthen its vision to continue providing innovative solutions to the sector and solidify its presence in the region,” said Fernando Cruz, President of
CINDE.
Currently, AVNA employs 150 people at its Costa Rica facility and expects to generate around 200 new jobs in key areas such as engineering, manufacturing, automation, and quality control over the next 3 years.
AVNA’s Costa Rica plant has been recognized with the Excellence in Innovation and Technology Award for its manufacturing of titanium micro-implants used in oncology treatments. The company has also been highlighted for its commitment to economic and social development, supporting initiatives that improve the quality of life in the communities where it operates.
About AVNA
With three strategic locations in New Britain, CT (Headquarters), Berlin, CT, and Grecia, Alajuela, Costa Rica and a dedicated workforce of 425+ employees, AVNA INC. is a trusted global engineering and manufacturing partner for the medical device industry with a reputation for producing the highest quality, complex components and subassemblies.
About CINDE
CINDE is the expert and strategic guide for investment, business development, and talent initiatives in Costa Rica. With more than 43 years of experience working with multinational companies and being a key player in the investment ecosystem, CINDE has developed numerous talent initiatives as a critical element of Costa Rica’s business climate and has supported the establishment of over 450 multinational companies.
